Filter By Industry
Filter By Tag

Newsroom

G&A RP Press releases

11 - 15 of 15 Press Releases

Oct 31, 2019
One of the main benefits of Belviq® is its safety, as it is not a stimulant nor a narcotic. Another benefit is that the patient continues to lose weight over time.

Sep 17, 2019
The objective is to achieve visibility, acknowledgement and offer incentive to physicians that develop innovative products and solutions to improve population's quality of life and well-being.

Jun 24, 2019
With this acquisition, the company takes the 21st position in the Chilean market and becomes the 4th largest regional-owned pharmaceutical company in the country.

Apr 30, 2019
Sustainable entrepreneurship platform in Latin America in partnership with Endeavor, encourages innovation in health area

Mar 19, 2019
The new treatment, currently in clinical development stage, shows promising results and the expectation is that it reaches the market as of 2022/2023.


Page: Prev 1 2
G&A RP RSS Feed